# A Pilot Study to Assess the Effects of a Novel Application of Averaged Volume Assured Pressure Support Ventilation (AVAPS-AE) Therapy on Re-hospitalization in Patients With Sleep-Disordered Breathing With Co-morbid COPD

> **NCT02446769** · NA · TERMINATED · sponsor: **Philips Respironics** · enrollment: 18 (actual)

## Conditions studied

- Breathing-Related Sleep Disorder

## Interventions

- **DEVICE:** AVAPS-AE Non-invasive ventilation therapy

## Key facts

- **NCT ID:** NCT02446769
- **Lead sponsor:** Philips Respironics
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-10-06
- **Primary completion:** 2018-05-03
- **Final completion:** 2018-05-21
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** Difficulty recruiting patient population.
- **Last updated:** 2020-08-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02446769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02446769, "A Pilot Study to Assess the Effects of a Novel Application of Averaged Volume Assured Pressure Support Ventilation (AVAPS-AE) Therapy on Re-hospitalization in Patients With Sleep-Disordered Breathing With Co-morbid COPD". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02446769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*